← Leaderboards
Thomas Moshang
Children'S Hospital Of Philadelphia
$190,685
Attributed
$190,685
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$190,685 · 4
By mechanism
M01$190,685 · 4
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Of Philadelphia
Same institution · by research overlap
- Babette S Zemel$12,389,104
- Lorraine E Katz$8,145,157
- Virginia A. Stallings$5,342,144
- Charles Alfred Stanley$21,958,556
- Raanan Arens$6,384,151
Others in their field
Top investigators on “Somatotropin”
- Brian E Henderson · University Of Southern California$17,806,295
- Johannes D Veldhuis · University Of Virginia Charlottesville$14,094,397
- Dan M Cooper · University Of California San Diego$13,278,892
- Stanley B Prusiner · University Of California San Francisco$12,108,025
- Steven Kyle Grinspoon · Massachusetts General Hospital$11,432,307
- David J Waxman · Boston University Medical Campus$10,042,015
Research focus
SomatotropinBone DensityClinical ResearchHormone TherapyHuman SubjectHuman Therapy EvaluationEndocrine DisorderQuality Of LifeQuestionnairesAdolescence (12-20)Longitudinal Human StudyPhoton AbsorptiometryCardiovascular FunctionChild Physical DevelopmentPituitary DwarfismDisease /Disorder Onset
Grant awards (6)
A RANDOMIZED, MULTICENTER, DOUBLE-BLIND TRIAL OF SANDOSTATIN LAR DEPOT (40MG) VS$3,010
M01 · FY2005 · RR
NORDITROPIN IN CHILDREN WITH GROWTH FAILURE ASSOCIATED WITH IGF DEFICIENCY$430
M01 · FY2005 · RR
GROWTH HORMONE REPLACEMENT THERAPY IN CHILDHOOD ONSET HORMONE DEFICIENCY$186,685
M01 · FY2002 · RR
GENOTROPIN USE IN GROWTH HORMONE DEFICIENT ADOLESCENTS$0
M01 · FY2002 · RR
GROWTH HORMONE REPLACEMENT THERAPY IN CHILDHOOD ONSET HORMONE DEFICIENCY$560
M01 · FY2000 · RR
GENOTROPIN USE IN GROWTH HORMONE DEFICIENT ADOLESCENTS$0
M01 · FY2000 · RR